HealthcareServices

Multiplex Assays Market Forecast: How Big Will It Be by 2030?

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the multiplex assays market from 2026–2035 with trusted insights from The Business Research Company

How is the Multiplex Assays Market size predicted to change over the forecast window of 2026–2035?

The multiplex assays market has experienced robust expansion in its size over recent years. Projections indicate it will expand from $3.88 billion in 2025 to reach $4.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. Historically, this growth has been driven by factors such as the rise in molecular diagnostic usage, growing demand for pcr-based testing, expansion of research activities, increased pathogen identification needs, and early adoption of multiplex protein assays.

The multiplex assays market is projected to experience substantial growth in the coming years, with its size expected to reach $5.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. This anticipated expansion during the forecast period is driven by advancements in multiplex technologies, a growing adoption of clinical diagnostics, increasing applications in precision medicine, wider utilization in forensic laboratories, and a rising demand for genetic mutation analysis. Key trends for the forecast period include the increasing uptake of multiplex PCR for pathogen detection, a greater deployment of multiplex assays in mutation and gene analysis, an escalating need for high-throughput protein quantification, the broadening of multiplex platforms within clinical diagnostics, and the enhanced utilization of multiplex assays in forensic and research investigations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

Which Drivers Are Contributing To The Expansion Of The Multiplex Assays Market?

The rising prevalence of chronic illnesses is anticipated to propel the expansion of the global multiplex assay market in the coming years. These are persistent medical conditions that progress slowly over time and generally necessitate ongoing management, often impacting multiple organ systems and overall quality of life. A significant contributor to the growing occurrence of chronic diseases is the aging demographic, as advancing age increases physiological vulnerability, reduces regenerative capacity, and extends exposure to cumulative risk factors, thereby making individuals more prone to the development and worsening of long-term health issues. Multiplex assays facilitate the concurrent measurement of several biomarkers, aiding in earlier detection, more precise disease monitoring, and improved clinical decision-making for those dealing with chronic conditions. For example, in April 2024, Allergy UK, a UK-based national charity, reported that more than 21 million people in the UK suffer from allergies, which became the most commonly reported chronic health condition in 2022, and projections indicate that by 2026, half of Europe’s population will experience at least one allergy. Consequently, the increasing incidence of chronic diseases is fueling the multiplex assay market.

What Segment Classifications Make Up The Multiplex Assays Market?

The multiplex assays market covered in this report is segmented –

1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types

2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies

3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies

4) By Application: Research And Development, Clinical Diagnostics

5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Subsegments:

1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay), Luminex xMAP Technology, Western Blotting, Immunohistochemistry, Mass Spectrometry-Based Assays

2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction), qPCR (Quantitative PCR), NGS (Next-Generation Sequencing), Microarray Analysis, RT-PCR (Reverse Transcription PCR)

3) By Other Types: Cell-Based Multiplex Assays, Bioanalytical Assays, Imaging-Based Assays, Surface Plasmon Resonance (SPR) Assays

Which Innovation Trends Are Advancing Developments Within The Multiplex Assays Market?

Major companies engaged in the multiplex assays market are concentrating on developing groundbreaking advancements, like ultrasensitive multiplexed digital PCR assays, to improve the precision of mutation detection and support more efficient clinical research processes. Ultrasensitive multiplexed digital PCR assays are high-accuracy analytical tools capable of identifying and quantifying multiple genetic variants present in low concentrations within a single reaction, thereby enhancing sensitivity while also reducing sample usage and the time required for testing. As an illustration, in January 2024, Bio-Rad Laboratories Inc., a US-based company focused on life science research and clinical diagnostic products, introduced the ddPLEX ESR1 Mutation Detection Kit. This kit is the inaugural ultrasensitive multiplexed digital PCR assay specifically engineered for detecting breast cancer mutations in the context of clinical research. The assay facilitates the simultaneous detection and quantification of seven known relevant ESR1 mutations in a single well, thus streamlining the testing workflow. It boasts an analytical sensitivity reaching as low as 0.01% variant allele fraction (VAF), which permits the discovery of low-frequency mutations that can be crucial in cancer diagnostics. The kit can be utilized with circulating tumor DNA (ctDNA) from plasma or DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissue samples, offering flexibility in the types of samples for analysis.

Which Major Firms Are Strengthening Their Position In The Multiplex Assays Market?

Major companies operating in the multiplex assays market are Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Which Regions Are Projected To Dominate The Multiplex Assays Market In The Coming Years?

North America was the largest region in the multiplex assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Multiplex Assays Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5775&type=smp

Browse Through More Reports Similar to the Global Multiplex Assays Market 2026, By The Business Research Company

Cell Based Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Multiplex Pcr Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

Multiplex Biomarker Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795